With the introduction of the ammonium sulphate precipitation (Farr) technique, a sensitive procedure for the detection of antibodies to either native deoxyribonucleic acid (nDNA) or heat-denatured singlestranded deoxyribonucleic acid (sDNA) has become available (Wold, Young, Tan, and Farr, 1968) . Furthermore, quantitation of the amount of antibody present in the test serum can be expressed with greater accuracy and as a continuous variable. Previous studies have shown the value of this method for the detection of anti-DNA antibody (described as DNAbinding) in systemic lupus erythematosus (SLE) and have suggested its use as a definitive test for the diagnosis of, and also for following the course of, disease activity (Hughes, 1971; Hughes, Cohn, and Christian, 1971; Pincus, Schur, Rose, Decker, and Talal, 1969) .
On occasions it is difficult to make a clinical distinction between rheumatoid arthritis and SLE. Furthermore, LE cells and antinuclear antibodies are present at times in both diseases. A test to discriminate between them would be useful. However, no systematic analysis had been done to determine the prevalence of antibody to nDNA in a large group of patients with well-characterized rheumatoid arthritis. This has been done in the current study and the results show that antibodies to nDNA are only rarely present in the serum of the patient with rheumatoid arthritis.
Materials and methods

PATIENT SELECTION
Sixty-two patients with rheumatoid arthritis who were either hospitalized or being treated as outpatients were studied. A group of local rheumatologists selected these patients on the basis of their having unequivocal rheumatoid arthritis and meeting the A.R.A. criteria for definite or classical disease (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) . The data collected included patient's age, sex, erythrocyte sedimentation rate, an estimation of the number of joints actively involved with arthritis at the time of the examination, and a judgement on the overall severity of the disease process. The presence or absence of extra-articular manifestations of rheumatoid arthritis was also recorded. These included weight loss, nodules, fever, digital arteritis, cardiopulmonary abnormalities, symptoms of Sjogren's syndrome, peripheral neuropathy, or Felty's syndrome.
LABORATORY STUDIES
DNA-binding assay
The source of radio-active DNA was a phenol extract of KB cells, a human tumour cell line, grown in the presence of tritium (3H) labelled thymidine (Electronucleonics, Bethesda, Md.). Serum DNA binding activity was determined by the method of Pincus and others (1969) . A Nuclear-Chicago scintillation counter was used to measure the radioactivity. DNA binding was expressed as the per cent. of radioactivity precipitated by 50 % saturated ammonium sulphate. Serum from 30 normal subjects showed less than 10% binding.*
Other laboratory procedures
Rheumatoid factor was measured by the bentonite flocculation technique (Bloch and Bunim, 1959) ; serum immunoglobulins (IgG, IgA, and IgM) and the third component of complement (C3) were quantified by radial immunodiffusion employing Hyland plates (Hyland Laboratories, Los Angeles, Calif.). Antinuclear antibodies were detected by an indirect immunofluorescent technique employing mouse kidney cells as the source of nuclei (Zvaifler and Martinez, 1971) .
Results
CLINICAL CHARACTERIZATION
Sixty-two patients with definite or classical rheumatoid arthritis were studied. 49 (80%) were female and thirteen (20%) male. The total average age was 51-8 years, with the average age of the females being 5l13 years and of the males being 53-4 years.
Nineteen patients had their disease for 2 years or less, thirteen patients for between 2 to 5 years, nine for 5 to 10 years, and 21 had the disease for more than 10 years. The median duration then fell in the group from 2 to 5 years. Using a semi-quantitative grading system for, the severity of joint involvement, it was found that 24 patients had what was considered to be mild disease activity, 25 had moderate, and ten were characterized as severe. Two patients were in remission, and data were not available for one patient. A recent erythrocyte sedimentation rate (predominantly by the Westergren technique) was available for 51 patients; the mean value was 40 mm/hr. 38 of the 62 patients had current extra-articular manifestations such as digital arteritis, neuropathy, nodules, Sjogren's syndrome, pulmonary involvement, etc.
SEROLOGICAL STUDIES
Fifty-four (85 7 %) of the patients had a positive test for rheumatoid factor-defined as a bentonite flocculation test (BFT) positive in a serum dilution of 1:32 or higher. The range of values is shown in Table I . The mean titre was 512. Fluorescent antinuclear antibody (FANA) determinations were posi- (Carr, Koffler, Agnello, and Kunkel, 1969; Hughes, 1971; Hughes and others, 1971; Koffler, Carr, Agnello, Thoburn, and Kunkel, 1971; Pincus and others, 1969; Wold and others, 1968) . To date, the only other diseases reported to have a significant incidence of antinative DNA antibody have been discoid lupus erythematosus-8 of 22 patients (Mandel, Carr, Weston, Sams, Harbeck, and Krueger, 1972) , and Sjogren's syndrome-6 of 24 subjects with increased binding (Pincus and others, 1969) . Both disorders have many features in common with SLE. Using a solid phase radioimmunoassay, Epstein, Tan, and Easterbrook (1971) found that the serum of 24% of patients with idiopathic and secondary uveitis contained antibodies to double-stranded (native) DNA. The meaning of this finding is uncertain at the present time.
Because rheumatoid arthritis and SLE share a number of clinical and serological features, it was considered of interest to examine serum from a large group of typical rheumatoid patients for the presence of DNA binding activity. Their binding was compared with a control group. The serum nDNA binding of thirty normal subjects was found to be less than 10% (mean + 1 standard deviation). Three of the 62 rheumatoid patients showed greater than 100% binding, but only one exceeded 20%. Hughes (1971) included twenty patients with adult rheumatoid arthritis and 14 with juvenile rheumatoid arthritis as controls in his study of anti-native DNA antibodies in SLE. The highest binding was 11 %, observed in a child with rheumatoid arthritis who subsequently developed manifestations of SLE and the diagnosis was changed accordingly (G. R. V. Hughes, personal communication, 1973) .
Only one of ten rheumatoid subjects studied by Carr and others (1969) showed more than 10% binding. Binding of greater than 20% was found in three of 57 disease controls recorded by Pincus and his coworkers (1969) . One of these had rheumatoid arthritis, another, Felty's syndrome. None of the three patients with increased DNA binding in the present study had clinical evidence of Sjogren's or Felty's syndrome, though more than half of the entire group had extra-articular manifestations of rheumatoid arthritis. The serum of approximately 20% of the rheumatoid patients had antinuclear antibody, but there was no correlation with DNA binding activity. Thus, the demonstration of significant amounts of antibody to native DNA in patients with arthritis and positive antinuclear antibody tests would strongly favor the diagnosis of SLE.
Antibodies to denatured (single stranded) DNA do not have the same specificity as antibodies to nDNA, since they are found in a variety of diseases where evidence of tissue injury exists. In one series more than 50 % of rheumatoid arthritis patients had serum antibodies to ssDNA (Koffler and others, 1971) . To exclude the possibility that the increased binding observed in this study was due to contamination of the nDNA by denatured DNA, the radiolabelled DNA was subjected to cesium gradient analysis. More The significance of a negative rheumatoid factor test in the two patients with the highest levels of DNA binding is unclear. They did not seem to differ significantly in terms of their clinical or laboratory parameters from the others in the group. It will, however, be interesting to determine whether a small subgroup of rheumatoid patients exists with significant DNA binding and negative rheumatoid factors, and whether their clinical presentation or course of disease activity is different.
Summary
Detection of anti-DNA antibodies using the ammonium sulphate precipitation technique has been studied in systemic lupus erythematosus and found to be of value. Data are presented on the prevalence of antinative DNA antibodies in a group of 62 wellcharacterized patients with rheumatoid arthritis. 59 of the 62 patients had negative values (binding less than 10%), and the other three patients had binding capacities of 13, 19, and 23 %. Interestingly, the latter two patients had negative rheumatoid factor tests, whereas 86 % of the entire group was positive. These data suggest that antibodies to native deoxyribonucleic acid are only rarely present in the serum of the patient with rheumatoid arthritis. 
